Generac Holdings Free cash flow decreased by 30.8% to $89.89M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 230.3%, from $27.22M to $89.89M. Over 3 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -3.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $95.70M | $41.18M | $39.22M | -$38.34M | -$74.38M | -$42.54M | $53.22M | $116.32M | $265.60M | $85.08M | $49.71M | $183.66M | $286.12M | $27.22M | $14.47M | $96.50M | $129.94M | $89.89M |
| QoQ Change | — | -57.0% | -4.8% | -197.8% | -94.0% | +42.8% | +225.1% | +118.5% | +128.3% | -68.0% | -41.6% | +269.4% | +55.8% | -90.5% | -46.8% | +566.7% | +34.7% | -30.8% |
| YoY Change | — | — | — | — | -280.6% | -10.9% | — | +256.4% | — | +300.0% | -6.6% | +57.9% | +7.7% | -68.0% | -70.9% | -47.5% | -54.6% | +230.3% |